Status:
COMPLETED
Three Month Clinical Evaluation of the Contamac 74% Silicone Hydrogel Contact Lens
Lead Sponsor:
Contamac Ltd
Conditions:
Vision Correction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to compare the clinical performance of the contamac silicone hydrogel contact lens with a predicate device (Cooper Vision Biofinity).
Detailed Description
The purpose of this study is to evaluate the clinical performance of the Contamac lens in comparison with a currently marketed silicone hydrogel: Biofinity® (CooperVision). This is a 3-month, open-lab...
Eligibility Criteria
Inclusion
- existing contact lens wearer
- read and signed statement of informed consent
- has clear central cornea
- requires spherical distance correction
Exclusion
- has worn RGP contact lenses within the last 30 days
- is using any ocular medication
- has had refractive surgery
- has an infectious disease
- is pregnant or lactating
- is participating in another clinical research study
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT01197859
Start Date
August 1 2008
End Date
February 1 2009
Last Update
August 12 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vision Care Research
Farnham, Surry, United Kingdom, GU9 7EN